Angiocidal effect of cyclosporin A: A new therapeutic approach for pathogenic angiogenesis

International Angiology

Volumn 24, Issue 4, 2005, Pages 372-379

  Wilasrusmee, C ^a   Yusupov, I ^b   Ondocin, P ^b   Bruch, D ^b   Kittur, S ^b   Wilasrusmee, S ^b   Kittur, D S ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Endothelium; Matrigel; Neoplasms

Indexed keywords

ANGIOGENESIS INHIBITOR; CYCLOSPORIN A; DRUG VEHICLE; FIBROBLAST GROWTH FACTOR; HEPARIN; MATRIGEL; TACROLIMUS; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; VASCULAR DISEASE; VASCULARIZATION;

ANIMALS; COLLAGEN; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 1; FOLLOW-UP STUDIES; HEPARIN; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; LAMININ; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30844448988     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hernandez GL, Volpert OV, Iniguez MA, Lorenzo E, Martinez-Martinez S, Grau R et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001;193: 607-20.
2. Iurlaro M, Vacca A, Minischetti M, Ribatti D, Pellegrino A, Sardanelli A et al. Antiangiogenesis by cyclosporine. Exp Hematol 1998;26:1215-22.
3. Gottsch JD, Akpek EK. Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc 2000;98:81-7; discussion 87-90.
4. Ribatti D, Vacca A, Cantatore FP, Ria R, Benagiano V, Roncali L, Dammacco F. An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis. Inflamm Res 2000;49:418-23.
5. Vajkoczy P, Vollmar B, Wolf B, Menger MD. Effects of cyclosporine A on the process of vascularization of freely transplanted islets of Langerhans. J Mol Med 1999;77: 111-4.
6. Bisogno G, Cowie F, Boddy A, Thomas HD, Dick G, Pinkerton CR. High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours. Br J Cancer 1998;77:2304-9.
7. Samuels BL, Mick R, Vogelzang NJ, Williams SF, Schilsky RL, Safa AR et al. Modulation of vinblastine resistance with cyclosporine: a phase I study. Clin Pharmacol Ther 1993;54:421-9.
8. Wilasrusmee C, Da Silva M, Singh B, Kittur S, Siddiqui J, Bruch D et al. A new in vitro model to study endothelial injury. J Surg Res 2002;104:131-6.
9. Claffey KP, Abrams K, Shih SC, Brown LF, Mullen A, Keough M. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab Invest 2001;81:61-75.
10. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A 1993;90:1937-41.
11. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995;170:39-49.
12. Woolfson RG, Neild GH. Cyclosporin nephrotoxicity following cardiac transplantation. Nephrol Dial Transplant 1997;12:2054-6.
13. Da Silva MS, Siddiqui J, Halverson A, Wilasrusmee C, Bruch D, Kittur DS. Beta 1-integrin-ligand disengagement induces in vitro capillary tube disruption mediated by p38 MAPK activity Surgery 2003;134:164-8.
14. Norrby K. Cyclosporin is angiostatic. Experientia 1992;48:1135-8.
15. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96: 34-40.
16. Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990;1:162-79.